HCV microelimination in harm reduction centres has benefits beyond HCV cure but is hampered by high reinfection rates

Authors:

Abstract
No abstract available
Funding Information
  • Asociación Española para el Estudio del Hígado
  • Instituto de Salud Carlos III
  • European Social Fund Plus
  • Societat Catalana de Digestologia
  • Gilead Sciences (IN-ES-987-5349)